Clinical Trial Update: The Effect of Deep Versus Moderate Muscle Relaxants in Men During and After Robotic Surgery for Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating deep versus moderate neuromuscular blockade during robotic prostate cancer surgery, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Deep neuromuscular blockade agent
• Moderate neuromuscular blockade agent

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-06-19